Thursday, September 21, 11:30 - 12:30 PM
AstraZeneca believe the best way to meet today’s science challenges is to work openly and collaboratively with the world’s best scientists. In May 2016, they moved their global headquarters to Cambridge (UK) to partner with academic, research and healthcare neighbours to make life-changing discoveries—and ultimately push the boundaries of science. The construction of their future home on the Cambridge Biomedical Campus is well underway, with a topping out in April 2017.
In 2018, around 2,000 AstraZeneca and MedImmune R&D science staff will being their move to the Cambridge Biomedical Campus, bringing together small molecule and biologics research and development activity across its main research areas. Designed by Herzog & de Meuron, the new facility is a triangular glass disc with rounded edges that hovers over six rectangular glass laboratory boxes forming an open courtyard, a traditional typology element of the Cambridge colleges. The street level is open and porous with both amenities and science on display in the laboratories.
The presentation will be led by AstraZeneca, Abell Nepp and BDP who will highlight the business strategy and user perspectives, as well as the architectural, laboratory and engineering design concepts and the construction progress.